Restatement of Previously Issued Financial Statements (Tables)

7 Months Ended

Dec. 31, 2020

Condensed Financial Information Disclosure [Abstract]

Schedule of the restatement on each financial statement

	As
	Previously						As
	Reported			Adjustments			Restated
Balance sheet as of August 20, 2020
Warrant Liability	$	—		$	30,645,000		$	30,645,000
Common Stock Subject to Possible Redemption		285,817,300			(30,645,000	)		255,172,300
Common Stock		1,004			306			1,310
Additional Paid-in Capital		5,000,015			4,306,214			9,306,210
Accumulated Deficit		(1,013	)		(4,306,520	)		(4,307,533	)
Balance sheet as of September 30, 2020 (unaudited)
Warrant Liability	$	—		$	33,198,921		$	33,198,921
Common Stock Subject to Possible Redemption		300,465,469			(33,198,921	)		271,266,548
Common Stock		949			332			1,281
Additional Paid-in Capital		5,124,471			5,029,540			10,154,011
Accumulated Deficit		(125,414	)		(5,029,872	)		(5,155,286	)
Balance sheet as of December 31, 2020
Warrant Liability	$	—		$	147,602,681		$	147,602,681
Common Stock Subject to Possible Redemption		303,078,515			(147,602,683	)		155,475,83
Common Stock		963			1,476			2,439
Additional Paid-in Capital		6,511,411			119,432,158			125,943,569
Accumulated Deficit		(1,512,369	)		(119,433,632	)		(120,946,001	)
Shareholder’s Equity		5,000,001			6			5,000,007
Period from May 27, 2020 (inception) to September 30, 2020 (unaudited)
Change in fair value of warrant liability	$	—		$	723,352		$	723,532
Transaction costs allocable to warrant liability within formation and operational costs		—			4,306,520			4,306,520
Net loss		(125,414	)		(5,029,872	)		(5,155,286	)
Weighted average common shares subject to possible redemption outstanding, basic and diluted		30,138,480			(3,216,303	)		26,922,176
Weighted average non-redeemable common shares outstanding, basic and diluted		8,111,107			(2,799,035	)		5,312,072
Basic and diluted net loss per share, nonredeemable common stock		(0.02	)					(0.97	)
Period from May 27, 2020 (inception) to December 31, 2020
Change in fair value of warrant liability	$	—		$	115,127,112		$	115,127,112
Transaction costs allocable to warrant liability within formation and operational costs		—			4,306,520			4,306,520
Net loss		(1,512,369	)		(119,433,632	)		(120,946,001	)
Weighted average common shares subject to possible redemption outstanding, basic and diluted		30,351,355			(3,287,735	)		27,063,620
Weighted average non-redeemable common shares outstanding, basic and diluted		8,691,291			2,005,636			10,696,927
Basic and diluted net loss per share, nonredeemable common stock		(0.18	)					(11.31	)
Cash Flow Statement for the Period from May 27, 2020 (inception) to December 31, 2020
Net loss	$	(1,512,369	)	$	(119,433,632	)	$	(120,946,001	)
Change in fair value of warrant liabilities		—			115,127,112			115,127,112
Share-based compensation for warrant liabilities		—			3,092,846			3,092,846
Transaction costs allocable to warrant liabilities		—			1,213,674			1,213,674
Initial classification of warrant liabilities		—			32,475,569			32,475,569